The J-elongated conformation of b2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome

Autor: Mathivanan Chinnaraj, Zhiwei Chen, Francesco Tedesco, Vittorio Pengo, Eliza A. Ruben, William Planer, Vincenzo De Filippis, Xiaobing Zuo, Nicola Pozzi, Paolo Macor, Ravi Kumar Alluri, Keith R. McCrae
Přispěvatelé: Ruben, E., Planer, W., Chinnaraj, M., Chen, Z., Zuo, X., Pengo, V., de Filippis, V., Alluri, R. K., Mccrae, K. R., Macor, P., Tedesco, F., Pozzi, N.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
single-molecule biophysics
Antiphospholipid
single-molecule biophysic
Biochemistry
Mutagenesi
structure-function
law.invention
lipid–protein interaction
HEK293 Cell
immune system diseases
law
Cricetinae
structural biology
thrombosi
Chemistry
autoimmunity
X-ray crystallography
antiphospholipid syndrome
autoimmune disease
beta-2 glycoprotein I
coagulation
complement system
protein–protein interaction
thrombosis
Animals
Antibodies
Antiphospholipid

HEK293 Cells
Humans
Kinetics
Mutagenesis
Protein Domains
beta 2-Glycoprotein I
Antiphospholipid Syndrome
Receptor–ligand kinetics
Protein Structure and Folding
Recombinant DNA
Human
Protein Domain
Protein domain
Antibodies
Protein–protein interaction
03 medical and health sciences
Beta 2-Glycoprotein I
Molecular Biology
Kinetic
030102 biochemistry & molecular biology
Animal
Cell Biology
Complement system
030104 developmental biology
Structural biology
Biophysics
Zdroj: J Biol Chem
Popis: β(2)-Glycoprotein I (β(2)GPI) is an abundant plasma protein displaying phospholipid-binding properties. Because it binds phospholipids, it is a target of antiphospholipid antibodies (aPLs) in antiphospholipid syndrome (APS), a life-threatening autoimmune thrombotic disease. Indeed, aPLs prefer membrane-bound β(2)GPI to that in solution. β(2)GPI exists in two almost equally populated redox states: oxidized, in which all the disulfide bonds are formed, and reduced, in which one or more disulfide bonds are broken. Furthermore, β(2)GPI can adopt multiple conformations (i.e. J-elongated, S-twisted, and O-circular). While strong evidence indicates that the J-form is the structure bound to aPLs, which conformation exists and predominates in solution remains controversial, and so is the conformational pathway leading to the bound state. Here, we report that human recombinant β(2)GPI purified under native conditions is oxidized. Moreover, under physiological pH and salt concentrations, this oxidized form adopts a J-elongated, flexible conformation, not circular or twisted, in which the N-terminal domain I (DI) and the C-terminal domain V (DV) are exposed to the solvent. Consistent with this model, binding kinetics and mutagenesis experiments revealed that in solution the J-form interacts with negatively charged liposomes and with MBB2, a monoclonal anti-DI antibody that recapitulates most of the features of pathogenic aPLs. We conclude that the preferential binding of aPLs to phospholipid-bound β(2)GPI arises from the ability of its preexisting J-form to accumulate on the membranes, thereby offering an ideal environment for aPL binding. We propose that targeting the J-form of β(2)GPI provides a strategy to block pathogenic aPLs in APS.
Databáze: OpenAIRE